Literature DB >> 10628375

Improved metastatic animal model of human prostate carcinoma using surgical orthotopic implantation (SOI).

X H Chang1, Y W Fu, W L Na, J Wang, H Sun, L Cai.   

Abstract

BACKGROUND: An animal model demonstrating high metastasis of human prostate carcinoma is of importance in studying the biology and therapy of human prostate carcinoma Dr. Hoffman's group recently used surgical orthotopic implantation (SOI) of human prostate cells to nude mice to establish an animal model with high metastatic activity. To confirm the animal model by SOI reproducible in other laboratories and shorten the period requiring for the metastasis, we adopted SOI technique with a modification using PC-3M human prostate cell line which showed a higher metastatic activity than PC-3.
MATERIALS AND METHODS: Intact tissue of the human prostate carcinoma cell line PC-3M was prepared by growth of this cell subcutaneous in a nude mouse. One piece of 1.5 mm3 intact tumor tissue was implanted by orthotopical surgery to the ventral lateral lobes of the prostate gland of 10 nude mice. Mice were sacrificed when they were found to be moribund. Metastasis in other tissues was evaluated by gross and microscopic morphology.
RESULTS: All 10 mice showed the tumorigenesis in the prostate gland and metastasis of human prostate tumor cells into periaortic lymph nodes without other organ's metastasis. The time when mice with PC-3M SOI start moribund is 28-32 days after SOI.
CONCLUSIONS: SOI is good technique to establish the efficiently metastatic animal mode. SOI using PC-3M human prostate cell line will leads to 100% metastasis of prostate tumor cells. So far, this model is much quicker and more efficient than those reported in literatures.

Entities:  

Mesh:

Year:  1999        PMID: 10628375

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Magnetic resonance imaging for the evaluation of a novel metastatic orthotopic model of human neuroblastoma in immunodeficient mice.

Authors:  R Moats; L Q Ma; R Wajed; Y Sugiura; A Lazaryev; M Tyszka; R Jacobs; S Fraser; M D Nelson; Y A DeClerck
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  Analyses of the role of endogenous SPARC in mouse models of prostate and breast cancer.

Authors:  Sunny Y Wong; Denise Crowley; Roderick T Bronson; Richard O Hynes
Journal:  Clin Exp Metastasis       Date:  2007-12-05       Impact factor: 5.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.